Plexxikon

Plexxikon

Engages in the discovery and development of small molecule pharmaceuticals to treat human disease.

Launch date
Employees
Market cap
-
Enterprise valuation
$30—45m (Dealroom.co estimates Mar 2005.)
Berkeley California (HQ)
  • Edit
DateInvestorsAmountRound
-

N/A

-

$26.9m

Early VC

$46.0m

Series B
N/A

$7.5m

Series B

$935m

Acquisition
Total Funding$80.4m

Recent News about Plexxikon

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Plexxikon

Edit
Plexxikon
ACQUISITION by Daiichi Sankyo Feb 2011